Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01481402
Other study ID # HerlevH
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date July 2011
Est. completion date February 2014

Study information

Verified date February 2014
Source Herlev Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Purpose: The purpose of the study is to examine if treatment with liothyronine increases left ventricular ejection fraction (LVEF) in patients with stable, chronic heart failure.


Description:

The patients are examined 3 times. At baseline, after 3 months and after 6 months.After the examination is performed, they begin the study medication while admitted at Dept. of Cardiology, Herlev Hospital, for cardiac monitoring.


Recruitment information / eligibility

Status Completed
Enrollment 21
Est. completion date February 2014
Est. primary completion date February 2014
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patients with stable, chronic systolic heart failure

- T3 =1.4 nmol/l in two blood samples, TSH is to be normal

- LVEF = 45 % on prior echocardiography

Exclusion Criteria:

- Established thyroid illness

- Atrial fibrillation/flutter

- More than 20% ventricular extrasystoles

- Severe chronic obstructive lung disorder

- Pregnancy. Pregnancy testing will be done for fertile women

- Age < 18 years

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Liothyronine
Liothyronine 40 microgram per day
Liothyronine
3 months of placebo followed by 3 months of Liothyronine 40 microgram per day (oral)

Locations

Country Name City State
Denmark Herlev Hospital, Dept. of Endocrinology Herlev

Sponsors (1)

Lead Sponsor Collaborator
Jens Faber

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Primary left ventricle ejection fraction The effect of liothyronine treatment in low dose in 3 months on LVEF. 3 months
Secondary Body composition The effect of 3 months low dose liothyronine treatment on body composition in patients with heart failure. 3 months
Secondary Quality of Life, questionaire The effect of 3 months low dose liothyronine treatment on quality of life, assessed by SF-36 and Minnesota Living with Heart Failure questionnaires in patients with heart failure. 3 months
Secondary YKL-40, YNF-alpha, hsCRP and IL-6 The effect of 3 months low dose liothyronine treatment on low grade inflammation assessed by measurement of pro-inflammatory markers in patients with heart failure. 3 months
Secondary RBP 4, HBA1C, adiponectin (high and low weight), glucose and HOMA-1 The effect of 3 months low dose liothyronine treatment on metabolic status in patients with heart failure. 3 months
Secondary GDF 8, SHBG, CK and PINP The effect of 3 months low dose liothyronine treatment on the extrathyroidal thyroid effect in patients with heart failure. 3 months
Secondary NT-proBNP, EDV and ESV The effect of 3 months low dose liothyronine treatment on heart function in patients with heart failure. 3 months
See also
  Status Clinical Trial Phase
Recruiting NCT05196659 - Collaborative Quality Improvement (C-QIP) Study N/A
Recruiting NCT05650307 - CV Imaging of Metabolic Interventions
Recruiting NCT05654272 - Development of CIRC Technologies
Active, not recruiting NCT05896904 - Clinical Comparison of Patients With Transthyretin Cardiac Amyloidosis and Patients With Heart Failure With Reduced Ejection Fraction N/A
Completed NCT05077293 - Building Electronic Tools To Enhance and Reinforce Cardiovascular Recommendations - Heart Failure
Recruiting NCT05631275 - The Role of Bioimpedance Analysis in Patients With Chronic Heart Failure and Systolic Ventricular Dysfunction
Enrolling by invitation NCT05564572 - Randomized Implementation of Routine Patient-Reported Health Status Assessment Among Heart Failure Patients in Stanford Cardiology N/A
Enrolling by invitation NCT05009706 - Self-care in Older Frail Persons With Heart Failure Intervention N/A
Recruiting NCT04177199 - What is the Workload Burden Associated With Using the Triage HF+ Care Pathway?
Terminated NCT03615469 - Building Strength Through Rehabilitation for Heart Failure Patients (BISTRO-STUDY) N/A
Recruiting NCT06340048 - Epicardial Injection of hiPSC-CMs to Treat Severe Chronic Ischemic Heart Failure Phase 1/Phase 2
Recruiting NCT05679713 - Next-generation, Integrative, and Personalized Risk Assessment to Prevent Recurrent Heart Failure Events: the ORACLE Study
Completed NCT04254328 - The Effectiveness of Nintendo Wii Fit and Inspiratory Muscle Training in Older Patients With Heart Failure N/A
Completed NCT03549169 - Decision Making for the Management the Symptoms in Adults of Heart Failure N/A
Recruiting NCT05572814 - Transform: Teaching, Technology, and Teams N/A
Enrolling by invitation NCT05538611 - Effect Evaluation of Chain Quality Control Management on Patients With Heart Failure
Recruiting NCT04262830 - Cancer Therapy Effects on the Heart
Completed NCT06026683 - Conduction System Stimulation to Avoid Left Ventricle Dysfunction N/A
Withdrawn NCT03091998 - Subcu Administration of CD-NP in Heart Failure Patients With Left Ventricular Assist Device Support Phase 1
Recruiting NCT05564689 - Absolute Coronary Flow in Patients With Heart Failure With Reduced Ejection Fraction and Left Bundle Branch Block With Cardiac Resynchronization Therapy